• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli and Israeli-related companies.

    Shavit Capital has over $400 million under management across five separate private equity funds. Shavit Capital was founded in 2008 and the fifth fund was raised in 2018.  The Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    The Foamix And Menlo Merger Makes Sense
    December 5, 2019
    Alpha Tau's new cancer radiology method proves effective
    December 2, 2019
    New Cancer Treatment Shows Promise in First Clinical Trial of Radiotherapy
    November 27, 2019
    Israeli dermatology co Foamix merging with US co Menlo David Domzalski
    November 11, 2019
    Mapi Announces First Patient Enrolled in the Phase III Clinical Trial of GA D
    October 28, 2019
    Foamix Enters Into Manufacturing and Supply Agreement For AMZEEQ™ and FMX10
    October 23, 2019
    Foamix Receives FDA Approval of AMZEEQ™ Topical Minocycline Treatment for M
    October 18, 2019
    Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocy
    October 17, 2019
    PolyPid Announces Positive Top-line Results from Phase 2 Clinical Trial of D-
    October 16, 2019
    Foamix Announces Enrollment of First Patient in Phase 2 Acne Clinical Trial f
    September 19, 2019